...
首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >A novel mutation in the albumin gene (R218S) causing familial dysalbuminemic hyperthyroxinemia in a family of bangladeshi extraction
【24h】

A novel mutation in the albumin gene (R218S) causing familial dysalbuminemic hyperthyroxinemia in a family of bangladeshi extraction

机译:孟加拉国提取家族中白蛋白基因(R218S)的新突变导致家族性dysalbuminemic高甲状腺素血症

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Familial dysalbuminemic hyperthyroxinemia (FDH) is a common cause of euthyroid hyperthyroxinemia. Clinical recognition of FDH is crucial for preventing unnecessary therapy in clinically euthyroid patients with abnormal thyroid function tests. Our goal was to identify the cause of abnormal serum tests of thyroid function in a Canadian family of Bangladeshi extraction. Patients: The proposita was found to have elevated free thyroxine (fT4) and free triiodothyronine (fT3) with nonsuppressed thyrotropin (TSH) on screening blood work. After detailed studies excluding hyperthyroidism and resistance to thyroid hormone, blood was obtained from all members of her immediate family for further investigation. Methods: We conducted laboratory analyses and sequencing of candidate genes. Results: Two members of this family have FDH, caused by a not previously identified mutation in the albumin gene. This mutation, located in exon 7 of the gene (652AC), produces a single amino acid substitution in the protein molecule (R218S). The mutant albumin is associated with a ninefold increase in serum total T4 and a twofold increase in serum total reverse T3 compared to patients with normal albumin. Modeling data for the R218S variant are compatible with the increased binding affinity of this variant albumin for T4. Conclusions: The R218S substitution reported here causes FDH that, in terms of the magnitude of serum iodothyronine elevation, is intermediate to the two previously reported mutations at codon 218 FDH: R218H being more mild and R218P more severe.
机译:背景:家族性水合白蛋白过高甲状腺素血症(FDH)是甲状腺功能亢进性甲状腺素高血症的常见原因。 FDH的临床认可对于预防甲状腺功能检查异常的临床甲状腺功能正常的患者至关重要。我们的目标是确定加拿大孟加拉提取物家族中甲状腺功能异常血清检查的原因。患者:在筛查血液功时,发现该proposita的游离甲状腺素(fT4)和游离三碘甲状腺素(fT3)升高而未抑制甲状腺素(TSH)。经过排除甲状腺功能亢进和对甲状腺激素抵抗性的详细研究后,从其直系亲属的所有成员中抽取了血液用于进一步调查。方法:我们对候选基因进行了实验室分析和测序。结果:该家族的两名成员患有FDH,这是由先前未发现的白蛋白基因突变引起的。此突变位于基因的外显子7(652A> C),在蛋白质分子(R218S)中产生单个氨基酸取代。与正常白蛋白患者相比,突变白蛋白与血清总T4增加9倍,血清总反向T3增加2倍有关。 R218S变体的建模数据与此变体白蛋白对T4的增加的结合亲和力兼容。结论:此处报道的R218S取代引起FDH,就血清碘甲状腺素升高的程度而言,是先前报道的两个218位密码子FDH突变的中间产物:R218H较轻,R218P更严重。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号